Miriam Silliman, MPH

About

Dr. Alex Doe is a molecular biologist and educator whose career spans over 15

years of research, teaching, and scientific leadership. They earned a Bachelor of

Science in Biochemistry from University X, where they first became fascinated by the

intricate ways cells communicate and regulate their internal processes. Building on

this foundation, they completed a PhD in Molecular Genetics at University Y, with a

dissertation focusing on the role of protein signaling pathways in cancer progression.

After earning their doctorate, Dr. Doe pursued postdoctoral training at the Genome

Research Institute, where they investigated the genetic and molecular mechanisms

underlying drug resistance in cancer cells. This work, conducted in collaboration with

both computational scientists and clinical oncologists, integrated high-throughput

genomic sequencing, bioinformatics modeling, and targeted laboratory experiments.

The findings contributed to new approaches for identifying biomarkers that can

predict treatment outcomes.

Department

Radiology

Academic Rank

Professor / Researcher

Staff Level

Staff

Students / Trainees

Medical Student

In 2015, Dr. Doe joined the faculty at University Z, where they established a

multidisciplinary research laboratory. The team’s projects span basic molecular

biology, translational research, and clinical collaborations. Current work in the lab

includes exploring gene-environment interactions in disease, mapping protein

networks that drive tumor growth, and developing diagnostic assays that can be

used in precision medicine.

Beyond research, Dr. Doe is recognized as a dedicated mentor and educator. They

have supervised over 20 graduate students and postdoctoral fellows, many of whom

have gone on to independent research careers. They regularly teach courses in

molecular genetics and experimental design, and are committed to building inclusive

and supportive learning environments for students from diverse backgrounds.

Dr. Doe is an active contributor to the scientific community, serving on editorial

boards, peer-review panels, and conference organizing committees. Their work has

been published in leading journals, and they are frequently invited to speak at

national and international meetings. They continue to pursue a long-term goal of

translating molecular discoveries into tangible improvements in patient care while

inspiring and equipping the next generation of scientists.

Outside of professional activities, Dr. Doe is passionate about science

communication and public outreach. They volunteer regularly with local schools,

museums, and community organizations to help make complex scientific topics

accessible to broader audiences. By bridging the gap between the lab and the

public, they hope to foster curiosity, critical thinking, and a greater appreciation for

the role of science in everyday life.

Education and Degree(s)

B.Sc. in Biochemistry, University of Pacifica, 2004 Completed an honors thesis

on enzymatic regulation in metabolic pathways.

M.Sc. in Molecular Biology, Eastern State University, 2006 Specialized in

cellular signaling mechanisms with a focus on cancer biology.

Ph.D. in Molecular Genetics, Northbridge University, 2011Dissertation

examined the genetic and epigenetic drivers of rare pediatric cancers.

Ph.D. in Molecular Genetics, Northbridge University, 2011 Dissertation

examined the genetic and epigenetic drivers of rare pediatric cancers.

Publications

Taylor J, Chen M, Rivera L, et al. (2023). Integrated multi-omics profiling reveals

novel biomarkers for early-stage pancreatic cancer. Journal of Translational

Oncology, doi: 10.1002/alz.12963.

Taylor J, Patel R, Nguyen K, et al. (2021). Epigenetic regulation of tumor

suppressor genes in triple-negative breast cancer. Nature Genetics, 53(8), 1124–

1136.. doi: 10.3389/fnagi.2022.903973. PMCID: PMC9340804

Taylor J, Wong E, Martínez R, et al. (2015). Kinase signaling pathways as

therapeutic targets in pediatric sarcomas. Molecular Cancer Therapeutics, 14(3),

642–652.

Taylor J, Alvarez S, Kwon J, et al. (2019). A bioinformatics pipeline for detecting

rare somatic mutations in clinical cancer genomics. BMC Genomics, 20(1), 612.

ELife 2022, 11:e77850. doi: 10.7554/eLife.77850. PMCID: PMC9217132

Honors and Awards

2023

Early Career Investigator Award – American Association for Cancer

2019

2017

Excellence in Teaching Award – UCLA David Geffen School of Medicine,

2019

Awarded for exceptional commitment to graduate student mentorship and

development of interdisciplinary training programs in biomedical data

science.

Research Innovation Grant – National Institutes of Health (NIH), 2017

Funded to support pioneering work in integrating genomic, transcriptomic,

and proteomic datasets for improved cancer diagnosis and treatment.